Preventing primary liver cancer: the HBV vaccination project in the Gambia (West Africa)
نویسنده
چکیده
The Gambia Hepatitis Intervention Study (GHIS) consisted in the progressive introduction of HBV plasma-derived vaccine in different zones of this African country during the period 1986-1990. The study was launched and coordinated by IARC and is one of the most effective examples of an intervention project that both substantially contributed to our knowledge and to the health of local populations. Similar intervention studies have been carried out in South-East Asia. The studies indicate that the natural history of HBV infection differs in different populations , having a direct relevance for the implementation of HBV vaccination programmes in various parts of the world.
منابع مشابه
Population-Based Interventions to Reduce the Public Health Burden Related with Hepatitis B Virus Infection in The Gambia, West Africa
In The Gambia, West Africa, the prevalence of chronic hepatitis B virus (HBV) infection in adults exceeds eight percent and hepatocellular carcinoma (HCC) has been the most frequent type of malignancy. Two population-based intervention studies to control HBV infection, namely, GHIS (Gambia Hepatitis Intervention Study) and PROLIFICA (Prevention of Liver Fibrosis and Cancer in Africa), are discu...
متن کامل20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West Africa
BACKGROUND The Gambia Hepatitis Intervention Study (GHIS) was designed as a randomised control trial of infant hepatitis B vaccination applied to public health policy, with the main goal of preventing primary liver cancer later in adult life in The Gambia. To that effect, the National Cancer Registry of The Gambia (NCR), a population-based cancer registry (PBCR), was established in 1986 to acti...
متن کاملPrevention of Hepatitis B- Related Liver Fibrosis and Liver Cancer in Africa: the Prolifica Project
CANCER CONTROL 2015 97 H epatitis B virus (HBV) infection is endemic in subSaharan Africa (SSA). However, the full impact of HBV-related liver disease and liver cancer remains poorly characterized in SSA. Access to screening and treatment programmes is severely limited and HBV treatment guidelines tailored to the African setting do not currently exist. The Prevention of Liver Fibrosis and Cance...
متن کاملEpidemiology and trends in mortality from liver cancer in Iran
Liver cancer is the sixth most common cancer worldwide and the third leading cause of death from cancer. Liver cancer is more prevalent in countries in East Asia, Southeast Asia and the western Central Africa.1 Liver cancer rates in North America and Western Europe, less than 10 cases per hundred thousand people in Asia and Africa between 50-150 cases per hundred thousand people.2 The inc...
متن کاملThe gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa
BACKGROUND Simple and inexpensive non-invasive fibrosis tests are highly needed but have been poorly studied in sub-Saharan Africa. METHODS Using liver histology as a gold standard, we developed a novel index using routine laboratory tests to predict significant fibrosis in patients with chronic HBV infection in The Gambia, West Africa. We prospectively assessed the diagnostic accuracy of the...
متن کامل